Latest news
H.C. Wainwright reiterates Buy on NeuroPace stock after FDA feedback - Investing.comInvesting.com · Wed, 29 Jul 2026 07:00:00 GMTNeuroPace FDA Bid for Expanded Epilepsy Use Stalls as Agency Seeks More Data - TradingViewTradingView · Tue, 28 Jul 2026 22:04:18 GMTNeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy - Business WireBusiness Wire · Tue, 28 Jul 2026 20:01:00 GMT